Bionet India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.60 M
- Revenue Growth 21.02%
- Profit Growth 47.14%
- Ebitda 266.16%
- Net Worth -1.82%
- Total Assets -5.05%
About Bionet India
Bionet India Pvt. Ltd. (BIPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 June 2001 and has a history of 23 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.60 M.
Gobind Aggarwal and Nirmla Devi serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231DL2001PTC111192
- Company No.
111192
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
E-Commerce
What products or services does Bionet India Pvt. Ltd. offer?
Bionet India Pvt. Ltd. offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Pharmaceutical Tablets, Ayurvedic Herbal Syrups & Tonics, Herbal Cough Syrup.
Who are the key members and board of directors at Bionet India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gobind Aggarwal  | Director | 08-Jun-2001 | Current |
| Nirmla Devi | Director | 10-Jan-2007 | Current |
Financial Performance of Bionet India.
Bionet India Pvt. Ltd., for the financial year ended 2022, experienced significant growth in revenue, with a 21.02% increase. The company also saw a substantial improvement in profitability, with a 47.14% increase in profit. The company's net worth dipped by a decrease of 1.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bionet India?
In 2020, Bionet India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹2.60 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.20 Cr
- Others : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Oct 2018 | Others | ₹0.60 M | Open |
| 18 May 2007 | Canara Bank | ₹2.00 M | Open |
How Many Employees Work at Bionet India?
Unlock and access historical data on people associated with Bionet India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bionet India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bionet India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
